Status:
COMPLETED
Effect of Adding Dexmedetomidine As Adjuvant to Bupivacaine in US Guided ESPB for Post MRM Pain Management
Lead Sponsor:
Abanoub Habib
Conditions:
Erector Spinae Plane Block
Eligibility:
FEMALE
30-65 years
Phase:
NA
Brief Summary
The aim of the study is to assess the effect of adding dexmedetomidine to bupivacaine in US guided erector spinae plane block in modified radical mastectomy surgeries , Using visual analogue score and...
Detailed Description
Breast cancer is one of the most important medical problems in the female gender, since among every eight women, one will suffer from breast cancer during her lifetime. Acute post-operative pain is v...
Eligibility Criteria
Inclusion
- Age:30-65years.
- Physical status: ASA I,II.
- BMI\<35.
- Localized breast cancer
Exclusion
- Age:\<30 and \>65 years.
- Refusal of procedure or participation in the study by the patient.
- Physical status: ASA III or above.
- History of allergy to the study drug.
- BMI\>35.
- Bleeding disorders and coagulopathy.
- Psychiatric illness that may interfere with the study.
- Metastatic breast cancer.
Key Trial Info
Start Date :
August 15 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2024
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06022614
Start Date
August 15 2023
End Date
July 1 2024
Last Update
October 2 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of Medicine Ain Shams University
Cairo, Egypt, 1181